Skip to main content
DiaSorin
Company
Research & Development
Immunodiagnostic Solutions
Molecular Solutions
People Culture
Investor Relations
FDA approves 1,25 Vitamin D in the US market
16/12/2014 - 00:00
Document type:
Immunodiagnostics
download file
Investor Relations
Consolidated data
Information for Shareholders
Financial Calendar
Annual & Interim Reports
Presentations
Press Releases
Coverage
Corporate Governance
Contacts for investors
IR Policy
IR Alerts service
Search form
Search
Scroll down
â–¼
close
Android
Iphone